Scalper1 News
Shares of highly rated drugmakers Celgene (CELG), Lannett (LCI) and Akorn (AKRX) rose Monday, while a pair of small drug companies plunged on negative reports. Celgene and its partner Acceleron Pharma (XLRN) said the Food and Drug Administration granted fast-track designation to luspatercept to treat patients who have the blood disease beta thalassemia as a result of transfusions or other causes. The FDA’s fast-track status allows a company to Scalper1 News
Scalper1 News